By proceeding, you agree to our Terms of Use and Privacy Policy.
Nanome is a software company that is changing the way humanity understands and interacts with science. Using Virtual Reality our technology accelerates innovation and understanding in an intuitive manner.
26-28 September 2022
For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible. Despite this, the first-ever FDA-approved KRAS G12C inhibitor has demonstrated that RAS is in fact druggable and that drugging
Event Ended
USA
Paid
Boston
11-12 October 2022
The field of protein degradation has accelerated, and substantial interest is owed to its promise to therapeutically degrade proteins proving intractable to classical small molecule inhibition. As the field patiently waits for clinical trial readouts
Switzerland
Basel
17-20 October 2022
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We
Hybrid
26-27 October 2022
Protein engineering has shaped the direction for biocatalysis being integrated into the workflow of large pharma globally. With the toolkit for enzyme design and discovery improving rapidly, this community is now presented with an enormous array of o
Philadelphia
10-13 April 2023
Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting op
San Diego
26-28 September 2023
5th Annual RAS-Targeted Drug Development SummitPersonalizing Medicine Via Targeting Oncogenic RAS for CancerWith the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable!
30-02 November 2023
The 6th Targeted Protein Degradation Summit is the premier event for professionals in the field of protein degradation drug development. Returning to Boston in 2023, this summit has established itself as the longest-standing and most comprehensive ga